Parkinson’s disease, which is also known as Parkinsonism, is a neurological disorder characterized by motor loss and problems with movement. Common symptoms include tremors, loss of balance, rigidity, difficulty walking, stiffness, lack of stamina, and involuntary movements such as sneezing, talking, swallowing, and gagging. Parkinson’s disease can be genetically linked and also can be the result of a series of disorders, including tuberculosis, diabetes, Parkinson’s hereditary ( hereditary Parkinson’s disease ) and CFS. A recent study from the University of Pennsylvania School of Medicine found that monosodiumglutamate, a substance found in many processed foods, may play a role in developing parkinson’s disease. This was the first evidence linking the two.
The National Institute of Mental Health has released many study related to Parkinsons disease. One study, published in May 2021 in the Journal of the National Medical Association, showed a significantly higher risk of women than men for parkinson’s disease. The paper, which was titled ” Associations of N-acetyl-d Glucosamine With parkinsonism: A prospective study,” concluded that the substance might help protect nerve cells from cell death due to parkinsonism. Another study, this one published in the Journal of Neuropsychology, showed that there is a relationship between a substance found in aspirin and parkinsonism. The study did not show a direct link between the two, but researchers have expressed concerns about the safety of using aspirin as a treatment for Parkinsons.
More about it on Oren Zarif website orenzarifenergy.com
Researchers in New Zealand have been studying how to prevent parkinson’s disease. A team from Massey-Harris county hospital in New Zealand has been studying patients who have early onset parkinsons disease, and how the disease progresses over time. The scientists are studying how to stop the protein amyloid peptides from damaging the brain cells and neurons in the body. Their findings have been reported in the peer-reviewed Journal of Neuropathology. The research is part of larger studies being conducted by the scientists to determine how to treat parkinsons.
Parkinsons is a progressive neurodegenerative disorder which causes the loss of the muscle motor coordination and ability to move the body. The disease is one of the most commonly used terms for a group of disorders which result in a loss of the central nervous system. This disease can be caused by many factors including genetics, viral infections, strokes and much more. There is no cure for Parkinsons, but there are many treatments available to keep the symptoms from disrupting daily life. Some patients live virtually un-scarred and independently, while others are in deep emotional turmoil.
How to prevent Parkinson’s disease, some ask? The most common treatment for patients with mild forms of the disease is a form of drug therapy known as antiparkinson. This drug, taken over time, prevents cell death which results in a slowing of the neurological processes in the brain. Over time, this lowers the risks of degeneration and generates the symptoms that are associated with the disease. This is the treatment most frequently recommended for patients who do not have complete onset of the disease. While the benefits of this form of treatment are very important, the downside of it is that it takes much time to take effect and must be continued for life.
Other forms of medication that are used for how to prevent Parkinson’s disease are anticonvulsants and antidepressants. Taking these drugs does seem to help slow down the progression of the disease, but the side effects are very unpleasant. And even with the benefits of treatment, patients often find that they must take these drugs for the rest of their lives.